ROCKVILLE, Md., May 21, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that on Friday, May 18, 2012, it sold 10,000,000 shares of its common stock to RA Capital Healthcare Fund, LP at a price of $1.22 per share. The shares were offered under an effective shelf registration statement previously filed with the Securities and Exchange Commission.
